https://www.selleckchem.com/pr....oducts/aristolochic-
inical pathway for cancer patients with, or at risk, of cardiotoxicity. © The Author(s). 2019.Background 5-Fluorouracil (5-FU) is an antimetabolite chemotherapy used for a variety of solid tumors. It has the potential to cause a wide spectrum of cardiotoxicity, ranging from asymptomatic electrocardiographic changes to cardiomyopathy and subsequent cardiac failure. Main body of the abstract We present two descriptive cases of new-onset severe cardiomyopathy induced by 5-FU followed by a review of the literature. Conclusion Ou
Aimer
Commentaire
Partagez
